Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With PT for Brain and Skull Base Tumors.
04/03/2018
/
Publications
To examine the rate of and identify risk factors for vasculopathy after proton therapy in pediatric patients with central nervous system and skull base tumors...
Proton therapy for locally advanced breast cancer: A systematic review of the literature.
11/11/2017
/
Publications
/
IMPT
This systematic review reported that protons offered a better target coverage than photons, even compared with intensity modulation radiation therapy (including...
Minimal toxicity after PBT for prostate and pelvic nodal irradiationresults, proton collaborative group REG001-09 trial.
11/10/2017
/
Publications
/
Toxicity
This PCG study evaluated toxicity outcomes for non-metastatic prostate cancer patients who received pelvic radiation therapy.
The study demonstrated PBT...
Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer.
11/11/2017
/
Publications
/
Hypofractionation
A study reported toxicity of 526 localized prostate cancer patients treated with proton therapy and demonstrated the safety of HFPT for localized PCa patients...
Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer.
11/12/2017
/
Publications
/
Chemotherapy
Compared the relative risk of radiation-induced lymphopenia between IMRT and PBT in esophageal cancer (EC) patients undergoing neoadjuvant chemoradiation...
Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma (EC).
11/06/2017
/
Publications
/
IMPT
Chemotherapy
Toxicity
19 patients with EC treated with IMPT concurrently with chemotherapy. Clinical complete response was achieved in 84%.
The most common grade 3 acute toxicities...
Proton therapy for pediatric head and neck malignancies.
11/10/2017
/
Publications
A study conducted by the UPenn group reported acute toxicities and early outcomes following PBT for pediatric head and neck malignancies.
The study...
Proton Beam Therapy for Iris Melanomas in 107 Patients.
11/11/2017
/
Publications
A study reported outcomes of 107 iris melanoma patients treated with protons.
Proton therapy showed efficacy and limited morbidity in iris melanomas.
Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
06/09/2017
/
Publications
/
Reirradiation
Toxicity
This review assessed clinical outcomes and toxicity profiles by evaluating available evidence regarding PBT reRT. The authors posit that PBT may be the safest...
Evidence-based Review on the Use of PT in Lymphoma from the PTCOG Lymphoma Subcommittee.
05/09/2017
/
Publications
In an effort to draw attention to the use of proton therapy in lymphoma, and as a resource for future consideration of proton therapy coverage for lymphoma by...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.